Progesterone receptor positive tumor
Information
- Disease name
- Progesterone receptor positive tumor
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04086875 | Active, not recruiting | N/A | A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer | November 7, 2018 | September 24, 2024 |
| NCT02668666 | Active, not recruiting | Phase 2 | Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer | June 30, 2016 | November 2023 |
| NCT02957968 | Active, not recruiting | Phase 2 | Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca | January 24, 2017 | February 28, 2025 |
| NCT00066690 | Active, not recruiting | Phase 3 | Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer | December 17, 2003 | December 2025 |
| NCT03870399 | Completed | Phase 2 | Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression | March 13, 2019 | May 13, 2023 |
| NCT01385280 | Completed | N/A | Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer | February 2011 | October 2013 |
| NCT01548534 | Terminated | Phase 3 | A Randomised Study of Docosahexaenoic Acid (DHA) in Metastatic Breast Cancer | February 2012 | June 2014 |
| NCT02000375 | Terminated | Phase 2 | A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT) | March 2013 | February 2016 |